Thomas Dick

12.2k total citations · 1 hit paper
201 papers, 8.5k citations indexed

About

Thomas Dick is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Thomas Dick has authored 201 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Infectious Diseases, 123 papers in Epidemiology and 83 papers in Molecular Biology. Recurrent topics in Thomas Dick's work include Tuberculosis Research and Epidemiology (132 papers), Mycobacterium research and diagnosis (113 papers) and Antibiotic Resistance in Bacteria (35 papers). Thomas Dick is often cited by papers focused on Tuberculosis Research and Epidemiology (132 papers), Mycobacterium research and diagnosis (113 papers) and Antibiotic Resistance in Bacteria (35 papers). Thomas Dick collaborates with scholars based in Singapore, United States and Germany. Thomas Dick's co-authors include Véronique Dartois, Martin Gengenbacher, Kévin Pethe, Helena I. Boshoff, Clifton E. Barry, Calvin Boon, Srinivasa P. S. Rao, Dinah B. Aziz, Dirk Schnappinger and Sabine Ehrt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Thomas Dick

195 papers receiving 8.3k citations

Hit Papers

The spectrum of latent tuberculosis: rethinking the biolo... 2009 2026 2014 2020 2009 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Dick Singapore 49 5.4k 4.4k 3.8k 1.1k 942 201 8.5k
Tanya Parish United States 50 5.0k 0.9× 3.8k 0.9× 4.0k 1.1× 939 0.9× 807 0.9× 195 7.8k
Mamadou Daffé France 63 7.6k 1.4× 7.5k 1.7× 5.3k 1.4× 1.3k 1.2× 1.7k 1.8× 191 12.6k
Delphi Chatterjee United States 52 4.2k 0.8× 4.8k 1.1× 3.0k 0.8× 585 0.6× 1.7k 1.8× 137 8.7k
Catherine Vilchèze United States 46 3.6k 0.7× 2.6k 0.6× 3.3k 0.9× 862 0.8× 872 0.9× 85 6.3k
Helena I. Boshoff United States 56 6.8k 1.3× 4.6k 1.1× 5.7k 1.5× 1.5k 1.5× 2.0k 2.1× 171 11.2k
Dirk Schnappinger United States 49 7.0k 1.3× 5.3k 1.2× 5.5k 1.5× 1.5k 1.4× 410 0.4× 115 11.1k
Kévin Pethe Singapore 40 2.9k 0.5× 2.3k 0.5× 2.4k 0.6× 641 0.6× 519 0.6× 93 5.4k
Sabine Ehrt United States 56 7.1k 1.3× 5.5k 1.3× 5.3k 1.4× 1.4k 1.3× 302 0.3× 119 11.2k
Valerie Mizrahi South Africa 47 4.3k 0.8× 3.1k 0.7× 3.7k 1.0× 1.0k 1.0× 435 0.5× 142 7.0k
David R. Sherman United States 54 8.6k 1.6× 6.9k 1.6× 5.0k 1.3× 1.7k 1.6× 420 0.4× 125 12.5k

Countries citing papers authored by Thomas Dick

Since Specialization
Citations

This map shows the geographic impact of Thomas Dick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Dick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Dick more than expected).

Fields of papers citing papers by Thomas Dick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Dick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Dick. The network helps show where Thomas Dick may publish in the future.

Co-authorship network of co-authors of Thomas Dick

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Dick. A scholar is included among the top collaborators of Thomas Dick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Dick. Thomas Dick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dartois, Véronique & Thomas Dick. (2024). Toward better cures for Mycobacterium abscessus lung disease. Clinical Microbiology Reviews. 37(4). e0008023–e0008023. 6 indexed citations
2.
Negatu, Dereje A., Sung Jae Shin, Su‐Young Kim, et al.. (2023). Oral β-Lactam Pairs for the Treatment of Mycobacterium avium Complex Pulmonary Disease. The Journal of Infectious Diseases. 230(2). e241–e246. 4 indexed citations
3.
Ragunathan, Priya, Pearly Shuyi Ng, Samsher Singh, et al.. (2023). GaMF1.39’s antibiotic efficacy and its enhanced antitubercular activity in combination with clofazimine, Telacebec, ND-011992, or TBAJ-876. Microbiology Spectrum. 11(6). e0228223–e0228223. 6 indexed citations
4.
Sarathy, Jickky Palmae, Matthew Zimmerman, Martin Gengenbacher, Véronique Dartois, & Thomas Dick. (2022). Mycobacterium tuberculosis DprE1 Inhibitor OPC-167832 Is Active against Mycobacterium abscessus In Vitro. Antimicrobial Agents and Chemotherapy. 66(12). e0123722–e0123722. 14 indexed citations
5.
Negatu, Dereje A., Matthew Zimmerman, Véronique Dartois, & Thomas Dick. (2022). Strongly Bactericidal All-Oral β-Lactam Combinations for the Treatment of Mycobacterium abscessus Lung Disease. Antimicrobial Agents and Chemotherapy. 66(9). e0079022–e0079022. 23 indexed citations
6.
Negatu, Dereje A., Randy R. Miller, Christopher W. Boyce, et al.. (2022). Activity of Tricyclic Pyrrolopyrimidine Gyrase B Inhibitor against Mycobacterium abscessus. Antimicrobial Agents and Chemotherapy. 66(9). e0066922–e0066922. 9 indexed citations
7.
Lan, Tian, Uday S. Ganapathy, Sachin Sharma, et al.. (2022). Redesign of Rifamycin Antibiotics to Overcome ADP‐Ribosylation‐Mediated Resistance. Angewandte Chemie. 134(45). 2 indexed citations
8.
Lan, Tian, Uday S. Ganapathy, Sachin Sharma, et al.. (2022). Redesign of Rifamycin Antibiotics to Overcome ADP‐Ribosylation‐Mediated Resistance. Angewandte Chemie International Edition. 61(45). e202211498–e202211498. 15 indexed citations
9.
Robaa, Dina, Dereje A. Negatu, Nadine Álvarez, et al.. (2022). Structure–Activity Relationship of Anti-Mycobacterium abscessus Piperidine-4-carboxamides, a New Class of NBTI DNA Gyrase Inhibitors. ACS Medicinal Chemistry Letters. 13(3). 417–427. 9 indexed citations
10.
Ragunathan, Priya, Joon Shin, Malathy Sony Subramanian Manimekalai, et al.. (2021). Mycobacterium tuberculosis PanD Structure–Function Analysis and Identification of a Potent Pyrazinoic Acid-Derived Enzyme Inhibitor. ACS Chemical Biology. 16(6). 1030–1039. 8 indexed citations
11.
Boshoff, Helena I., et al.. (2021). Reinvestigation of the structure-activity relationships of isoniazid. Tuberculosis. 129. 102100–102100. 11 indexed citations
12.
Williams, John T., Garry B. Coulson, Edmund L. Ellsworth, et al.. (2019). Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance. Antimicrobial Agents and Chemotherapy. 63(10). 40 indexed citations
13.
Safi, Hassan, Pooja Gopal, Shuyi Ma, et al.. (2019). Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance. Proceedings of the National Academy of Sciences. 116(39). 19665–19674. 97 indexed citations
14.
Pasunooti, Kalyan Kumar, Yee Hwa Wong, Yok Hian Chionh, et al.. (2019). Thienopyrimidinone Derivatives That Inhibit Bacterial tRNA (Guanine37-N¹)-Methyltransferase (TrmD) by Restructuring the Active Site with a Tyrosine-Flipping Mechanism. Applied Categorical Structures. 1 indexed citations
15.
Gurumurthy, Meera, Tathagata Mukherjee, Cynthia S. Dowd, et al.. (2011). Substrate specificity of the deazaflavin‐dependent nitroreductase from Mycobacterium tuberculosis responsible for the bioreductive activation of bicyclic nitroimidazoles. FEBS Journal. 279(1). 113–125. 71 indexed citations
16.
Rao, Srinivasa P. S., Sylvie Alonso, Lucinda Rand, Thomas Dick, & Kévin Pethe. (2008). The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences. 105(33). 11945–11950. 401 indexed citations
17.
Teo, Jeanette, Pamela Thayalan, David Beer, et al.. (2006). Peptide Deformylase Inhibitors as Potent Antimycobacterial Agents. Antimicrobial Agents and Chemotherapy. 50(11). 3665–3673. 47 indexed citations
18.
Marques, Maria Angela M., Sebabrata Mahapatra, Devki Nandan, et al.. (2000). Bacterial and host-derived cationic proteins bind α2-laminins and enhance attachment to human Schwann cells. Microbes and Infection. 2(12). 1407–1417. 35 indexed citations
19.
Hutter, Bernd & Thomas Dick. (1999). Molecular genetic characterisation of whiB3, a mycobacterial homologue of a Streptomyces sporulation factor. 67. 513–514. 5 indexed citations
20.
Dick, Thomas & Hans Matzura. (1990). Chloramphenicol-induced translational activation of cat messenger RNA in vitro. Journal of Molecular Biology. 212(4). 661–668. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026